Nuclear factor kappa B(NF-κB) is one of the best-characterized transcription factors playing important roles in many cellular responses to a large variety of stimuli,including inflammatory cytokines, phorbol esters, ...Nuclear factor kappa B(NF-κB) is one of the best-characterized transcription factors playing important roles in many cellular responses to a large variety of stimuli,including inflammatory cytokines, phorbol esters, growth factors, and bacterial and viral products. The aim of this study is to demonstrate NF-κB expression in the mouse cochlea and its enhancement in response to lipopolysaccharides(LPS) and kanamycin(KA) treatment. Methods KA treatment consisted of subcutaneous KA injections at 700 mg/kg twice a day with an eight-hour interval between the two injections for 3 or 7 days. For animals in the LPS treatment group, a single dose of 0.3 mg LPS dissolved in 0.2 ml sterile saline were injected into both bullae through the tympanic membrane and kept there for 3 hours. Animals in the control group received subcutaneous saline injection for 7 days. Following immmunohistochemichal processing with rabbit polyclonal anti-NF-κB p65 antibodies, cryosections of the cochlea were examined for expression of NF-κB p65 in various structures in the cochlea. Results NF-κB p65 expression, identified by presence of brown reaction products characteristic of DAB immunohistochemistry, was visible in the spiral ligament, spiral prominence, tectorial membrane(TM), spiral ganglion and nerve fibers. Relatively weak NF-κB p65 expression was also visualized in the organ of Corti. Within the organ of Corti, the inner hair cells(IHC), outer hair cells(OHC), inner pillar cells(IP), outer pillar cells (OP), Deiter’s cells(DC), and Boettcher’s cells exhibited stronger staining than the inner sulcus cells, Hensen’s cells(HC) and Claudius’cells. No NF-κB p65 expression was seen in the nucleus of the IHC and OHC. NF-κB p65 expression was increased in animals exposed to LPS or KA, demonstrating significant differences in the staining between control animals and LPS/KA-treated animals. NF-κB p65 expression was not significantly different between LPS treated and KA treated animals or between 3 and 7 days in KA-treated animals. Conclusion LPS and KA exposure increases expression of NF-κB p65 in the mouse cochlea.展开更多
Activation of nuclear factor kappa B (NF-κB) is a hallmark of various central nervous system (CNS) pathologies. Neuron-specific inhibition of its transcriptional activator subunit RelA, also referred to as p65, p...Activation of nuclear factor kappa B (NF-κB) is a hallmark of various central nervous system (CNS) pathologies. Neuron-specific inhibition of its transcriptional activator subunit RelA, also referred to as p65, promotes neuronal survival under a range of conditions, i.e., for ischemic or excitotoxic insults. In macro- and microglial cells, post-lesional activation of NF-κB triggers a growth-permissive program which contributes to neural tissue inflammation, scar formation, and the expression of axonal growth inhibitors. Intriguingly, inhibition of such inducible NF-~B in the neuro-glial compartment, i.e., by genetic ablation of RelA or overexpression of a trans- dominant negative mutant of its upstream regulator IκBa, significantly enhances functional recovery and promotes axonal regeneration in the mature CNS. By contrast, depletion of the NF-κB subunit p50, which lacks transcriptional activator function and acts as a transcriptional repressor on its own, causes precocious neuronal loss and exacerbates axonal degeneration in the lesioned brain. Collectively, the data imply that NF-κB orchestrates a multicellular pro- gram in which κB-dependent gene expression establishes a growth-repulsive terrain within the post-lesioned brain that limits structural regeneration of neuronal circuits. Considering these subunit-specific functions, interference with the NF-κB pathway might hold clinical potentials to improve functional restoration following traumatic CNS injury.展开更多
Objective: To explore the underlying molecular mechanisms of cellular response to the challenge by 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis of PC12 cells, an in vitro cell model for Parkinson’s disease, a...Objective: To explore the underlying molecular mechanisms of cellular response to the challenge by 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis of PC12 cells, an in vitro cell model for Parkinson’s disease, and the effect of NF-κB activation on the protection of Parkinson’s disease by Isoflavone (I). Methods: PC12 cells were used to establish the cell model of Parkinson’s disease, and are divided into five groups: control group;MPP+ group;I (Isoflavone) + MPP+ group;I group;SN-50 + MPP+ group. The content of NF-κB in PC12 cells was determined by immunocytochemistry;The viability of PC12 cells after treated with cell-permeable NF-κB inhibitor SN-50 and cell viability were measured by MTT assay;the expression levels of NF-κB p65 in cytoplasm and nuclear fractions were evaluated by western blot analysis;the mRNA expression of NF-κB p65 was analyzed by in situ hybridization (ISH). Results: Compared with the control group, the protein of NF-κB p65 both in cytoplasm and in nuclei was significantly higher than in I + MPP+ and MPP+ groups;similarly, the mRNA expression level of NF-κB p65 gene was also significantly higher;moreover, the protein expression of NF-κB p65 was much lower in I group (P + group, the protein of NF-κB p65 was significantly lower in I + MPP+ group, the mRNA expression level of NF-κB p65 gene was also significantly lower, and the protein expression level of NF-κB p65 was much lower in I + MPP+ group (P + group (P > 0.05). Conclusion: NF-κB activation is essential to MPP+-induced apoptosis in PC12 cells;but Isoflavone can inhibit the cell damage to some extent to execute its protective function, which may be involved in nigral neurodegeneration in patients with Parkinson’s disease.展开更多
目的探讨白藜芦醇对脑胶质瘤细胞U251的增殖和上皮间质转化(EMT)的影响及对核转录子kappa B p65(NF-κB p65)通路的调节作用。方法将第3代对数生长期U251细胞随机分为对照组、白藜芦醇组、激动剂组和激动剂+白藜芦醇组,对照组细胞不做处...目的探讨白藜芦醇对脑胶质瘤细胞U251的增殖和上皮间质转化(EMT)的影响及对核转录子kappa B p65(NF-κB p65)通路的调节作用。方法将第3代对数生长期U251细胞随机分为对照组、白藜芦醇组、激动剂组和激动剂+白藜芦醇组,对照组细胞不做处理,白藜芦醇组细胞加入50μmol·L^(-1)白藜芦醇处理,激动剂组细胞加入1μg·mL^(-1)脂多糖(LPS)刺激,激动剂+白藜芦醇组细胞加入LPS 1μg·mL^(-1)刺激12 h后再用50μmol·L^(-1)白藜芦醇预处理12 h,MTT法检测细胞存活率,流式细胞仪检测细胞凋亡率,ELISA检测白细胞介素(IL)-6、IL-1β、肿瘤坏死因子α(TNF-α)含量,Transwell实验检测细胞侵袭能力以及蛋白印迹法检测上皮钙黏蛋白(E-cad)、神经钙黏蛋白(N-cad)、波形蛋白(vimentin)和p-p65蛋白相对表达量。结果与对照组比较,白藜芦醇组细胞存活率、IL-6、IL-1β、TNF-α含量以及N-cad、vimentin和p-p65蛋白相对表达量降低,侵袭细胞数减少,细胞凋亡率和E-cad蛋白相对表达量升高,激动剂组细胞存活率、IL-6、IL-1β、TNF-α含量以及N-cad、vimentin和p-p65蛋白相对表达量升高,侵袭细胞数增多,细胞凋亡率和E-cad蛋白相对表达量降低(P<0.05);与白藜芦醇组比较,激动剂+白藜芦醇组细胞存活率、IL-6、IL-1β、TNF-α含量以及N-cad、vimentin和p-p65蛋白相对表达量升高,侵袭细胞数增多,细胞凋亡率和E-cad蛋白相对表达量降低(P<0.05);与激动剂组比较,激动剂+白藜芦醇组细胞存活率、IL-6、IL-1β、TNF-α含量以及N-cad、vimentin和p-p65蛋白相对表达量降低,侵袭细胞数减少,细胞凋亡率以及E-cad蛋白相对表达量升高(P<0.05)。结论白藜芦醇可抑制脑胶质瘤细胞增殖和侵袭、促进其凋亡,其可能是通过抑制NF-κB信号通路减轻炎症反应、抑制上皮间质转化发挥调控作用的。展开更多
AIM:To study the inhibition of nuclear factor kappa-B p65(NF-κB p65)antisense oligodeoxynucleotide(ASODN)on transdifferentiation of normal human lens epithelial cells induced by transforming growth factor-β2(T...AIM:To study the inhibition of nuclear factor kappa-B p65(NF-κB p65)antisense oligodeoxynucleotide(ASODN)on transdifferentiation of normal human lens epithelial cells induced by transforming growth factor-β2(TGF-β2).·M ETHODS:NF-κBp65ASODNand NF-κBp65missense oligodeoxynucleotide(MSODN)were designed and synthesized.Human lens epithelial cell line(HLE B-3)cells were prepared for study and divided into 7 groups.Control group was HLE B-3 cells cultured in dulbecco’s modified eagle medium(DMEM).T1,T2,and T3 group were HLE B-3 cells cultured in DMEM with 10 ng/m L TGF-β2 for 6h,12h,24h respectively.A+T group was HLE B-3 cells cultured with 10 ng/m L TGF-β2for 24h after transfected by NF-κB p65 ASODN for 24h.M+T group was HLE B-3 cells cultured with 10 ng/m L TGF-β2 for 24h after transfected by NF-κB p65 MSODN for 24h.The negative control group was HLE B-3 cells cultured with 10 ng/m L TGF-β2 for 24h after cultured with transfer agent(Hi Per Fect)for 24h.Cell morphology was observed at different time points using an inverted microscope.The expression of NF-κB p65 m RNA was detected with reverse transcription-polymerase chain reaction(RT-PCR),and the expression ofα-smooth muscle actin(α-SMA)protein was assayed with ELISA.·RESULTS:With the TGF-β2 stimulation prolongation,the expression of NF-κB p65 m RNA and a-SMA protein increased in T1,T2,T3 groups compared with the control group,and the difference was statistically significant(〈0.05).NF-κB p65 ASODN lowered the expression of NF-κB p65 m RNA andα-SMA protein induced by TGF-β2.NF-κB p65 MSODN and Hi Per Fect did not lower the expression of NF-κB p65 m RNA andα-SMA protein induced by TGF-β2.The difference between control group and A+T group was not statistically significant(〉0.05),but the difference among A+T group and other groups was statistically significant(〈0.05).·CONCLUSION:NF-κB p65 ASODN could lower the expression of NF-κB p65 m RNA andα-SMA protein induced by TGF-β2,and antagonized TGF-β2-induced transdifferentiation of HLE B-3.NF-κB p65ASODN could be used as a new biological therapeutic target of posterior capsular opacification.展开更多
目的研究姜黄素对高脂诱导的非酒精性脂肪性肝病(NAFLD)中肝过氧化物酶体增殖物激活受体γ(PPAR-γ)和核因子κB(NF-κB)p65 m RNA及蛋白表达的影响。方法建立大鼠NAFLD模型,按照随机化原则分为5组:正常组、模型组、低剂量治疗组、中剂...目的研究姜黄素对高脂诱导的非酒精性脂肪性肝病(NAFLD)中肝过氧化物酶体增殖物激活受体γ(PPAR-γ)和核因子κB(NF-κB)p65 m RNA及蛋白表达的影响。方法建立大鼠NAFLD模型,按照随机化原则分为5组:正常组、模型组、低剂量治疗组、中剂量治疗组、高剂量治疗组。正常组给予普通饮食,其余4组给予高脂饮食,同时分别用羧甲基纤维素钠(CMC)和低、中、高剂量姜黄素进行治疗。持续治疗12周后,处死各组大鼠并进行处理分析。血清生物化学方法检测大鼠血清中谷丙转氨酶(ALT)、谷草转氨酶(AST)、甘油三酯(TG)和总胆固醇(TC)的含量;HE染色对大鼠肝组织进行病理学观察;免疫组织化学检测大鼠肝组织PPAR-γ和NF-κB p65蛋白的表达情况;RT-PCR检测PPAR-γ和NF-κB p65 m RNA的表达情况。结果治疗组(低、中、高剂量)大鼠血清中ALT、AST、TG、TC含量较模型组明显降低(P<0.05)。治疗组(低、中、高剂量)大鼠肝组织的脂肪变性程度较模型组明显减轻。与正常组比较,模型组肝组织PPAR-γm RNA及蛋白的表达水平均明显降低(P<0.05),而NF-κB p65 m RNA及蛋白的表达水平均明显升高(P<0.05)。与模型组比较,治疗组(低、中、高剂量)大鼠肝组织PPAR-γ的表达明显增加(P<0.05),PPAR-γ的表达水平以高剂量治疗组升高更加明显(P<0.01);与模型组相比,治疗组(低、中、高剂量)大鼠肝组织NF-κB p65的表达显著减少(P<0.05),NF-κB p65的表达水平以高剂量治疗组降低更加明显(P<0.01)。结论姜黄素可明显减轻高脂诱导的大鼠NAFLD肝组织的脂肪变性和炎性反应,其抗脂肪变性和抗炎的机制可能与姜黄素激活PPAR-γ的表达,从而抑制NF-κB p65的活性有关。PPAR-γ和NF-κB p65的表达参与了NAFLD的发生发展,控制这些信号分子的表达可能是姜黄素治疗NAFLD的重要机制之一。展开更多
文摘Nuclear factor kappa B(NF-κB) is one of the best-characterized transcription factors playing important roles in many cellular responses to a large variety of stimuli,including inflammatory cytokines, phorbol esters, growth factors, and bacterial and viral products. The aim of this study is to demonstrate NF-κB expression in the mouse cochlea and its enhancement in response to lipopolysaccharides(LPS) and kanamycin(KA) treatment. Methods KA treatment consisted of subcutaneous KA injections at 700 mg/kg twice a day with an eight-hour interval between the two injections for 3 or 7 days. For animals in the LPS treatment group, a single dose of 0.3 mg LPS dissolved in 0.2 ml sterile saline were injected into both bullae through the tympanic membrane and kept there for 3 hours. Animals in the control group received subcutaneous saline injection for 7 days. Following immmunohistochemichal processing with rabbit polyclonal anti-NF-κB p65 antibodies, cryosections of the cochlea were examined for expression of NF-κB p65 in various structures in the cochlea. Results NF-κB p65 expression, identified by presence of brown reaction products characteristic of DAB immunohistochemistry, was visible in the spiral ligament, spiral prominence, tectorial membrane(TM), spiral ganglion and nerve fibers. Relatively weak NF-κB p65 expression was also visualized in the organ of Corti. Within the organ of Corti, the inner hair cells(IHC), outer hair cells(OHC), inner pillar cells(IP), outer pillar cells (OP), Deiter’s cells(DC), and Boettcher’s cells exhibited stronger staining than the inner sulcus cells, Hensen’s cells(HC) and Claudius’cells. No NF-κB p65 expression was seen in the nucleus of the IHC and OHC. NF-κB p65 expression was increased in animals exposed to LPS or KA, demonstrating significant differences in the staining between control animals and LPS/KA-treated animals. NF-κB p65 expression was not significantly different between LPS treated and KA treated animals or between 3 and 7 days in KA-treated animals. Conclusion LPS and KA exposure increases expression of NF-κB p65 in the mouse cochlea.
基金supported by the Leibniz Association,Germany,and the VELUX Foundation,Switzerland
文摘Activation of nuclear factor kappa B (NF-κB) is a hallmark of various central nervous system (CNS) pathologies. Neuron-specific inhibition of its transcriptional activator subunit RelA, also referred to as p65, promotes neuronal survival under a range of conditions, i.e., for ischemic or excitotoxic insults. In macro- and microglial cells, post-lesional activation of NF-κB triggers a growth-permissive program which contributes to neural tissue inflammation, scar formation, and the expression of axonal growth inhibitors. Intriguingly, inhibition of such inducible NF-~B in the neuro-glial compartment, i.e., by genetic ablation of RelA or overexpression of a trans- dominant negative mutant of its upstream regulator IκBa, significantly enhances functional recovery and promotes axonal regeneration in the mature CNS. By contrast, depletion of the NF-κB subunit p50, which lacks transcriptional activator function and acts as a transcriptional repressor on its own, causes precocious neuronal loss and exacerbates axonal degeneration in the lesioned brain. Collectively, the data imply that NF-κB orchestrates a multicellular pro- gram in which κB-dependent gene expression establishes a growth-repulsive terrain within the post-lesioned brain that limits structural regeneration of neuronal circuits. Considering these subunit-specific functions, interference with the NF-κB pathway might hold clinical potentials to improve functional restoration following traumatic CNS injury.
文摘Objective: To explore the underlying molecular mechanisms of cellular response to the challenge by 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis of PC12 cells, an in vitro cell model for Parkinson’s disease, and the effect of NF-κB activation on the protection of Parkinson’s disease by Isoflavone (I). Methods: PC12 cells were used to establish the cell model of Parkinson’s disease, and are divided into five groups: control group;MPP+ group;I (Isoflavone) + MPP+ group;I group;SN-50 + MPP+ group. The content of NF-κB in PC12 cells was determined by immunocytochemistry;The viability of PC12 cells after treated with cell-permeable NF-κB inhibitor SN-50 and cell viability were measured by MTT assay;the expression levels of NF-κB p65 in cytoplasm and nuclear fractions were evaluated by western blot analysis;the mRNA expression of NF-κB p65 was analyzed by in situ hybridization (ISH). Results: Compared with the control group, the protein of NF-κB p65 both in cytoplasm and in nuclei was significantly higher than in I + MPP+ and MPP+ groups;similarly, the mRNA expression level of NF-κB p65 gene was also significantly higher;moreover, the protein expression of NF-κB p65 was much lower in I group (P + group, the protein of NF-κB p65 was significantly lower in I + MPP+ group, the mRNA expression level of NF-κB p65 gene was also significantly lower, and the protein expression level of NF-κB p65 was much lower in I + MPP+ group (P + group (P > 0.05). Conclusion: NF-κB activation is essential to MPP+-induced apoptosis in PC12 cells;but Isoflavone can inhibit the cell damage to some extent to execute its protective function, which may be involved in nigral neurodegeneration in patients with Parkinson’s disease.
基金Supported by the Outstanding Young Medical Personnel of Qingdao City
文摘AIM:To study the inhibition of nuclear factor kappa-B p65(NF-κB p65)antisense oligodeoxynucleotide(ASODN)on transdifferentiation of normal human lens epithelial cells induced by transforming growth factor-β2(TGF-β2).·M ETHODS:NF-κBp65ASODNand NF-κBp65missense oligodeoxynucleotide(MSODN)were designed and synthesized.Human lens epithelial cell line(HLE B-3)cells were prepared for study and divided into 7 groups.Control group was HLE B-3 cells cultured in dulbecco’s modified eagle medium(DMEM).T1,T2,and T3 group were HLE B-3 cells cultured in DMEM with 10 ng/m L TGF-β2 for 6h,12h,24h respectively.A+T group was HLE B-3 cells cultured with 10 ng/m L TGF-β2for 24h after transfected by NF-κB p65 ASODN for 24h.M+T group was HLE B-3 cells cultured with 10 ng/m L TGF-β2 for 24h after transfected by NF-κB p65 MSODN for 24h.The negative control group was HLE B-3 cells cultured with 10 ng/m L TGF-β2 for 24h after cultured with transfer agent(Hi Per Fect)for 24h.Cell morphology was observed at different time points using an inverted microscope.The expression of NF-κB p65 m RNA was detected with reverse transcription-polymerase chain reaction(RT-PCR),and the expression ofα-smooth muscle actin(α-SMA)protein was assayed with ELISA.·RESULTS:With the TGF-β2 stimulation prolongation,the expression of NF-κB p65 m RNA and a-SMA protein increased in T1,T2,T3 groups compared with the control group,and the difference was statistically significant(〈0.05).NF-κB p65 ASODN lowered the expression of NF-κB p65 m RNA andα-SMA protein induced by TGF-β2.NF-κB p65 MSODN and Hi Per Fect did not lower the expression of NF-κB p65 m RNA andα-SMA protein induced by TGF-β2.The difference between control group and A+T group was not statistically significant(〉0.05),but the difference among A+T group and other groups was statistically significant(〈0.05).·CONCLUSION:NF-κB p65 ASODN could lower the expression of NF-κB p65 m RNA andα-SMA protein induced by TGF-β2,and antagonized TGF-β2-induced transdifferentiation of HLE B-3.NF-κB p65ASODN could be used as a new biological therapeutic target of posterior capsular opacification.
文摘目的研究姜黄素对高脂诱导的非酒精性脂肪性肝病(NAFLD)中肝过氧化物酶体增殖物激活受体γ(PPAR-γ)和核因子κB(NF-κB)p65 m RNA及蛋白表达的影响。方法建立大鼠NAFLD模型,按照随机化原则分为5组:正常组、模型组、低剂量治疗组、中剂量治疗组、高剂量治疗组。正常组给予普通饮食,其余4组给予高脂饮食,同时分别用羧甲基纤维素钠(CMC)和低、中、高剂量姜黄素进行治疗。持续治疗12周后,处死各组大鼠并进行处理分析。血清生物化学方法检测大鼠血清中谷丙转氨酶(ALT)、谷草转氨酶(AST)、甘油三酯(TG)和总胆固醇(TC)的含量;HE染色对大鼠肝组织进行病理学观察;免疫组织化学检测大鼠肝组织PPAR-γ和NF-κB p65蛋白的表达情况;RT-PCR检测PPAR-γ和NF-κB p65 m RNA的表达情况。结果治疗组(低、中、高剂量)大鼠血清中ALT、AST、TG、TC含量较模型组明显降低(P<0.05)。治疗组(低、中、高剂量)大鼠肝组织的脂肪变性程度较模型组明显减轻。与正常组比较,模型组肝组织PPAR-γm RNA及蛋白的表达水平均明显降低(P<0.05),而NF-κB p65 m RNA及蛋白的表达水平均明显升高(P<0.05)。与模型组比较,治疗组(低、中、高剂量)大鼠肝组织PPAR-γ的表达明显增加(P<0.05),PPAR-γ的表达水平以高剂量治疗组升高更加明显(P<0.01);与模型组相比,治疗组(低、中、高剂量)大鼠肝组织NF-κB p65的表达显著减少(P<0.05),NF-κB p65的表达水平以高剂量治疗组降低更加明显(P<0.01)。结论姜黄素可明显减轻高脂诱导的大鼠NAFLD肝组织的脂肪变性和炎性反应,其抗脂肪变性和抗炎的机制可能与姜黄素激活PPAR-γ的表达,从而抑制NF-κB p65的活性有关。PPAR-γ和NF-κB p65的表达参与了NAFLD的发生发展,控制这些信号分子的表达可能是姜黄素治疗NAFLD的重要机制之一。